PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 9 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,285,000 | +47.2% | 152,000 | 0.0% | 0.01% | +16.7% |
| Q1 2020 | $9,026,000 | -10.3% | 152,000 | -17.2% | 0.01% | +20.0% |
| Q4 2019 | $10,058,000 | +58.3% | 183,600 | -18.4% | 0.01% | +66.7% |
| Q3 2019 | $6,354,000 | -14.9% | 225,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $7,468,000 | -2.4% | 225,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $7,650,000 | +24.1% | 225,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,163,000 | -6.3% | 225,000 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $6,575,000 | – | 225,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |